Bristol-Myers Squibb Companys stock price (BMY) rose in latest intraday trading, supported by positive signals streaming from the Stochastic. With this rise, the stock has reached the resistance of the 50-day SMA, a level that gains further significance as it also aligns with a short-term descending trend line making it a key area for determining the next price direction.

Therefore, as long as the stock remains below the level of $48.26, we expect it to decline in upcoming trading, targeting the pivotal support of $44.00.

Todays price forecast: Bearish